Skip to main content
. 2022 Mar 28;11(18):3471–3478. doi: 10.1002/cam4.4707

TABLE 1.

Baseline characteristics of patients with pregnancy‐associated sarcomas (n = 13)

Variable
Patient age at sarcoma diagnosis (years)

Mean (SD)

28.54 (4.41)

Race n (%)
American Indian or Alaska Native 0 (0)
Asian 0 (0)
Black or African American 1 (7.7)
White or Caucasian 9 (69.2)
Other 1 (7.7)
Unknown/Refuse to Answer 2 (15.4)
Ethnicity n (%)
Hispanic 2 (15.4)
Non‐Hispanic 11 (84.6)
Time to diagnosis from onset of symptoms (months)

Mean (SD)

4.58 (5.75)

Stage at diagnosis n (%)
Localized 10 (76.9)
Metastatic 3 (23.1)
Location of primary tumor n (%)
Extremity 5 (38.5)
Lung 2 (15.4)
Chest wall 2 (15.4)
Pelvis 2 (15.4)
Abdominal wall 1 (7.7)
Mandible 1 (7.7)
Size of primary tumor at diagnosis (cm)

Mean (SD)

11.4 (7.31)

Diagnosis grouping n (%)
Bone sarcoma 4 (30.8)
Soft tissue sarcoma 9 (69.2)
Histology n (%)
Soft tissue sarcomas
Malignant peripheral nerve sheath tumor 1 (7.7)
Synovial sarcoma 1 (7.7)
Myxofibrosarcoma 1 (7.7)
High‐grade spindle cell sarcoma 1 (7.7)
Desmoid tumor 1 (7.7)
Unclassified small cell malignancy 1 (7.7)
High‐grade spindle cell sarcoma 2 (15.4)
Embryonal rhabdomyosarcoma 1 (7.7)
Bone sarcomas
Osteosarcoma 3 (23.1)
Ewing's sarcoma 1 (7.7)
Type of pregnancy n (%)
Natural 11 (84.6)
In vitro fertilization 1 (7.7)
Intrauterine insemination 1 (7.7)
Age of mother at conception (years)

Mean (SD)

28.5 (4.4)

Gestational age at diagnosis (weeks)

Mean (SD)

16.7 (5.9)